Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Leukemia, Prolymphocytic × Imatinib Mesylate × Clear all

Sponsor

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 36 Leukemia 26 Precursor Cell Lymphoblastic Leukemia-Lymphoma 15 Gastrointestinal Stromal Tumors 13 Leukemia, Myeloid, Chronic-Phase 12 Leukemia, Myeloid 6 Brain Neoplasms 6 Prostatic Neoplasms 5 Philadelphia Chromosome 5 Blast Crisis 5 Sarcoma 4 Recurrence 4 Glioblastoma 4 Carcinoma, Non-Small-Cell Lung 4 Bone Marrow Diseases 4 Ovarian Neoplasms 3 Melanoma 3 Lung Neoplasms 3 Leukemia, Myeloid, Acute 3 Hematologic Diseases 3 Bronchiolitis Obliterans Syndrome 3 Breast Neoplasms 3 Stomach Neoplasms 2 Polycythemia Vera 2 Neurofibromatoses 2 Neoplasms by Histologic Type 2 Neoplasms 2 Neoplasm Metastasis 2 Myeloproliferative Disorders 2 Meningioma 2

Interventions

fludarabine phosphate 22 Mycophenolic Acid 16 Whole-Body Irradiation 15 Peripheral Blood Stem Cell Transplantation 13 Cyclophosphamide 11 Tacrolimus 10 Cyclosporine 10 Antilymphocyte Serum 9 Cyclosporins 8 Busulfan 8 fludarabine 7 Rituximab 7 Methotrexate 5 Sirolimus 4 Melphalan 4 Filgrastim 3 Cytarabine 3 Cord Blood Stem Cell Transplantation 3 thymoglobulin 2 pegfilgrastim 2 ibrutinib 2 Thiotepa 2 Oxaliplatin 2 Granulocyte Colony-Stimulating Factor 2 Etoposide 2 Darbepoetin alfa 2 Clofarabine 2 selinexor 1 sargramostim 1 ofatumumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡